Search research articles
Contact Us
Filters
Showing results (51-60 of 182) with videos related to
Page
of 19
Sort By:
Plos One
|
September 28, 2013
Identification of therapeutic candidates for chronic lymphocytic leukemia from a library of approved drugs
Min Shen, Yaqin Zhang, Nakhle Saba, et al.
Plos One
|
June 24, 2011
Therapeutic potential and challenges of targeting receptor tyrosine kinase ROR1 with monoclonal antibodies in B-cell malignancies
Jiahui Yang, Sivasubramanian Baskar, Ka Yin Kwong, et al.
Oncotarget
|
February 18, 2017
Using high-sensitivity sequencing for the detection of mutations in BTK and PLCγ2 genes in cellular and cell-free DNA and correlation with progression in patients treated with BTK inhibitors
Adam Albitar, Wanlong Ma, Ivan DeDios, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2015
Treatment with Ibrutinib Inhibits BTK- and VLA-4-Dependent Adhesion of Chronic Lymphocytic Leukemia Cells In Vivo
Sarah E M Herman, Rashida Z Mustafa, Jade Jones, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 22, 2011
Phenotypic complexity of T regulatory subsets in patients with B-chronic lymphocytic leukemia
Angélique Biancotto, Pradeep K Dagur, John C Fuchs, et al.
JAMA Oncology
|
August 18, 2016
Seasonal Influenza Vaccination in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib
Clare Sun, Jin Gao, Laura Couzens, et al.
Leukemia & Lymphoma
|
September 21, 2023
Interruption of BTK inhibitor improves response to SARS-CoV-2 booster vaccination in patients with CLL
Emily Tomasulo, Shira Paul, Rui Mu, et al.
The Journal of Clinical Investigation
|
January 3, 2020
Bruton tyrosine kinase deficiency augments NLRP3 inflammasome activation and causes IL-1β-mediated colitis
Liming Mao, Atsushi Kitani, Eitaro Hiejima, et al.
Gigascience
|
October 2, 2019
IKAP-Identifying K mAjor cell Population groups in single-cell RNA-sequencing analysis
Yun-Ching Chen, Abhilash Suresh, Chingiz Underbayev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2021
Select Antitumor Cytotoxic CD8<sup>+</sup> T Clonotypes Expand in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib
Maria Joao Baptista, Sivasubramanian Baskar, Erika M Gaglione, et al.
Page
of 19
Search research articles
Search
Showing results (51-60 of 182) with videos related to
Sort By:
Page
of 19
Plos One
|
September 28, 2013
Identification of therapeutic candidates for chronic lymphocytic leukemia from a library of approved drugs
Min Shen, Yaqin Zhang, Nakhle Saba, et al.
Plos One
|
June 24, 2011
Therapeutic potential and challenges of targeting receptor tyrosine kinase ROR1 with monoclonal antibodies in B-cell malignancies
Jiahui Yang, Sivasubramanian Baskar, Ka Yin Kwong, et al.
Oncotarget
|
February 18, 2017
Using high-sensitivity sequencing for the detection of mutations in BTK and PLCγ2 genes in cellular and cell-free DNA and correlation with progression in patients treated with BTK inhibitors
Adam Albitar, Wanlong Ma, Ivan DeDios, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2015
Treatment with Ibrutinib Inhibits BTK- and VLA-4-Dependent Adhesion of Chronic Lymphocytic Leukemia Cells In Vivo
Sarah E M Herman, Rashida Z Mustafa, Jade Jones, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 22, 2011
Phenotypic complexity of T regulatory subsets in patients with B-chronic lymphocytic leukemia
Angélique Biancotto, Pradeep K Dagur, John C Fuchs, et al.
JAMA Oncology
|
August 18, 2016
Seasonal Influenza Vaccination in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib
Clare Sun, Jin Gao, Laura Couzens, et al.
Leukemia & Lymphoma
|
September 21, 2023
Interruption of BTK inhibitor improves response to SARS-CoV-2 booster vaccination in patients with CLL
Emily Tomasulo, Shira Paul, Rui Mu, et al.
The Journal of Clinical Investigation
|
January 3, 2020
Bruton tyrosine kinase deficiency augments NLRP3 inflammasome activation and causes IL-1β-mediated colitis
Liming Mao, Atsushi Kitani, Eitaro Hiejima, et al.
Gigascience
|
October 2, 2019
IKAP-Identifying K mAjor cell Population groups in single-cell RNA-sequencing analysis
Yun-Ching Chen, Abhilash Suresh, Chingiz Underbayev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2021
Select Antitumor Cytotoxic CD8<sup>+</sup> T Clonotypes Expand in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib
Maria Joao Baptista, Sivasubramanian Baskar, Erika M Gaglione, et al.
Page
of 19